MDxHealth (OTCMKTS:MXDHF) Trading Up 900%

MDxHealth SA (OTCMKTS:MXDHFGet Free Report)’s share price was up 900% on Monday . The company traded as high as $2.50 and last traded at $2.50. Approximately 1 shares traded hands during mid-day trading, a decline of 100% from the average daily volume of 1,000 shares. The stock had previously closed at $0.25.

MDxHealth Stock Up 900.0 %

The company has a debt-to-equity ratio of 1.45, a quick ratio of 1.19 and a current ratio of 1.25. The firm’s fifty day moving average is $0.33.

About MDxHealth

(Get Free Report)

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.

Further Reading

Receive News & Ratings for MDxHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MDxHealth and related companies with's FREE daily email newsletter.